期刊
EXPERIMENTAL NEUROLOGY
卷 166, 期 2, 页码 235-245出版社
ACADEMIC PRESS INC
DOI: 10.1006/exnr.2000.7516
关键词
Parkinson's disease; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; marmoset; mitochondrial dysfunction; free radicals; antioxidant; Ebselen; glutathione peroxidase mimicking; neuroprotection
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), via its major metabolite 1-methyl-4-phenylpyridinium (MPP+), produces in primates including humans clinical, biochemical, and neuropathological changes similar to those which occur in idiopathic Parkinson's disease. Ebselen is an antioxidant drug with glutathione peroxidase-like activity and a proven neuroprotective action in stroke patients. Here we show that Ebselen, when administered before, during, and after MPTP injections, prevents both neuronal loss and clinical symptoms in a primate MPTP model of Parkinson's disease. Ebselen also prevents peroxide radical overproduction induced by serum withdrawal in cultured PC12 cells and hydroxyl radical generation induced by the mitochondrial toxin, MPP+, in vivo in rat brain. Moreover, Ebselen inhibits MPP+-induced toxicity in PC12 cells, without interacting with the dopamine uptake system. Our results demonstrate that compounds which prevent mitochondrial dysfunction and free radical production may be useful as preventive treatment of Parkinson's disease. (C) 2000 Academic Press.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据